Motilal Oswal Sees Aster DM EBITDA Rising 25% CAGR Through FY28, Sets Rs 910 Target
Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and a target price of Rs 910, arguing that the healthcare provider is entering a stronger growth phase supported by merger synergies, capacity expansion and improving operating performance. The brokerage expects revenue, EBITDA and PAT to compound at 19.5%, 25% and 33%, respectively, through FY28, signalling confidence in both scale and margin expansion.
